Avalo Therapeutics, Inc. · NASDAQ:AVTX

Point72 Asset Management, L.P. reported a 5.20% stake in Avalo Therapeutics, Inc. (Schedule 13G)

Event May 22, 2026 · Filed May 26, 2026

Point72 Asset Management, L.P. reported a 5.20% stake in Avalo Therapeutics, Inc., 2,710,817 shares, as a passive investor on May 22, 2026. Filed May 26, 2026 (Schedule 13G).

Stake
5.20%
Shares
2,710,817
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Point72 Asset Management, L.P.5.20%2,710,817
Point72 Capital Advisors, Inc.5.20%2,710,817
Steven A. Cohen5.20%2,710,817

Source

View original at SEC

Related